• Immunotherapies, new gut peptides show promise for cardiometabolic diseases

    1 month ago - By Healio

    Emerging data suggest immunotherapies and novel peptides that target gut inflammation could serve as complementary agents to available diabetes drugs to more effectively target cardiometabolic diseases, according to a speaker.
    Atherosclerotic cardiovascular disease, obesity and metabolic syndrome have increased in prevalence worldwide, and understanding the pathogenesis of this cardiometabolic syndrome is essential for developing effective treatments, Theodoros Kelesidis, MD, PhD, associate professor of medicine at the University of California Los Angeles, said during a presentation at the
    Read more ...